Cargando…

Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition

Granulatimide and isogranulatimide are alkaloids obtained from marine sources which have been shown to inhibit cell-cycle G2-checkpoint, targeting more particularly checkpoint 1 kinase (Chk1). At a structural level, they possess a characteristic pyrrolocarbazole framework also shared by the well-kno...

Descripción completa

Detalles Bibliográficos
Autores principales: Deslandes, Sébastien, Chassaing, Stefan, Delfourne, Evelyne
Formato: Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810226/
https://www.ncbi.nlm.nih.gov/pubmed/20098609
http://dx.doi.org/10.3390/md7040754
_version_ 1782176662677356544
author Deslandes, Sébastien
Chassaing, Stefan
Delfourne, Evelyne
author_facet Deslandes, Sébastien
Chassaing, Stefan
Delfourne, Evelyne
author_sort Deslandes, Sébastien
collection PubMed
description Granulatimide and isogranulatimide are alkaloids obtained from marine sources which have been shown to inhibit cell-cycle G2-checkpoint, targeting more particularly checkpoint 1 kinase (Chk1). At a structural level, they possess a characteristic pyrrolocarbazole framework also shared by the well-known rebeccamycin and staurosporine microbial metabolites which have been described to inhibit topoisomerase I and diverse kinases, respectively. This review reports precisely on the synthesis and kinase inhibitory activities of pyrrolocarbazole-based analogues of granulatimide.
format Text
id pubmed-2810226
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Molecular Diversity Preservation International
record_format MEDLINE/PubMed
spelling pubmed-28102262010-01-22 Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition Deslandes, Sébastien Chassaing, Stefan Delfourne, Evelyne Mar Drugs Review Granulatimide and isogranulatimide are alkaloids obtained from marine sources which have been shown to inhibit cell-cycle G2-checkpoint, targeting more particularly checkpoint 1 kinase (Chk1). At a structural level, they possess a characteristic pyrrolocarbazole framework also shared by the well-known rebeccamycin and staurosporine microbial metabolites which have been described to inhibit topoisomerase I and diverse kinases, respectively. This review reports precisely on the synthesis and kinase inhibitory activities of pyrrolocarbazole-based analogues of granulatimide. Molecular Diversity Preservation International 2009-12-01 /pmc/articles/PMC2810226/ /pubmed/20098609 http://dx.doi.org/10.3390/md7040754 Text en © 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Deslandes, Sébastien
Chassaing, Stefan
Delfourne, Evelyne
Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition
title Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition
title_full Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition
title_fullStr Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition
title_full_unstemmed Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition
title_short Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition
title_sort marine pyrrolocarbazoles and analogues: synthesis and kinase inhibition
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810226/
https://www.ncbi.nlm.nih.gov/pubmed/20098609
http://dx.doi.org/10.3390/md7040754
work_keys_str_mv AT deslandessebastien marinepyrrolocarbazolesandanaloguessynthesisandkinaseinhibition
AT chassaingstefan marinepyrrolocarbazolesandanaloguessynthesisandkinaseinhibition
AT delfourneevelyne marinepyrrolocarbazolesandanaloguessynthesisandkinaseinhibition